The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Oral Anticoagulants and Intracranial Hemorrhage: Facts and Hypotheses
Abstract
Background Intracranial hemorrhage is the most feared and lethal complication of oral anticoagulation. We review the frequency, predictors, and prognosis of this most common neurological complication of oral anticoagulation. Summary of Review Anticoagulation to conventional intensities increases the risk of intracranial hemorrhage 7- to 10-fold, to an absolute rate of nearly 1%/y for many stroke-prone patients. Most (70%) anticoagulant-related intracranial hemorrhages are intracerebral hematomas (approximately 60% are fatal); the bulk of the remainder are subdural hematomas. Predictors of anticoagulant-related intracerebral hematoma are advanced patient age, prior ischemic stroke, hypertension, and intensity of anticoagulation. In approximately half of anticoagulated patients with intracerebral hematoma the bleeding evolves slowly over 12 to 24 hours, and emergency reversal of anticoagulation is crucial. Conclusions Both patient factors and anticoagulation intensity importantly influence the rate of anticoagulation-related intracranial hemorrhage. Patient-related risk factors for this complication overlap with those for ischemic stroke. The risk/benefit equation of anticoagulation for elderly, stroke-prone patients is complex and differs from that for younger patients. The absolute rate reduction (not the relative risk reduction) of ischemic stroke by anticoagulation is the critical issue and must offset accentuation of often lethal brain hemorrhage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Hylek, E. M., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00001 · Cited by 919
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
Landefeld, C. S., & Beyth, R. J. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90285-w · Cited by 893
Landefeld, C. S., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90564-0 · Cited by 778
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A. G. G., McLoughlin, D., Dodd, P., Thomas, M., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072704 · Cited by 728
Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study
Fihn, S. D., McDonell, M., Martin, D., Henikoff, J., Vermes, D., Kent, D., White, R. H., & for the Warfarin Optimized Outpatient Follow-up Study Group* (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00005 · Cited by 671
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
Smith, P., Arnesen, H., & Holme, I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230302 · Cited by 638
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
Turpie, A., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., & Hirsh, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290802 · Cited by 547
Cited by
Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., Stern, B. J., Hertzberg, V. S., Frankel, M. R., Levine, S. R., Chaturvedi, S., Kasner, S. E., Benesch, C. G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043033 · Cited by 1,744
Broderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., Mayberg, M., Morgenstern, L., Ogilvy, C. S., Vespa, P., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.183689 · Cited by 1,125
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage
Flibotte, J. J., Hagan, N., O’Donnell, J., Greenberg, S. M., & Rosand, J. (2004) · Neurology · doi:10.1212/01.wnl.0000138428.40673.83 · Cited by 632
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Easton, J. D., Sacco, R. L., & Teal, P. (1998) · Chest · doi:10.1378/chest.114.5_supplement.683s · Cited by 617
Man-Son-Hing, M., Nichol, G., Lau, A., & Laupacis, A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.7.677 · Cited by 538
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. (2004) · Chest · doi:10.1378/chest.126.3_suppl.483s · Cited by 466
Balser, D., Farooq, S., Mehmood, T., Reyes, M., & Samadani, U. (2015) · Journal of Neurosurgery · doi:10.3171/2014.9.jns141550 · Cited by 432
Woo, D., Sauerbeck, L. R., Kissela, B. M., Khoury, J. C., Szaflarski, J. P., Gebel, J., Shukla, R., Pancioli, A. M., Jauch, E. C., Menon, A. G., et al. (2002) · Stroke · doi:10.1161/01.str.0000014774.88027.22 · Cited by 419
(2006) · Cerebrovascular Diseases · doi:10.1159/000094831 · Cited by 411
Cerebral microbleeds on MRI: Prevalence, associations, and potential clinical implications
Koennecke, H.-C. (2006) · Neurology · doi:10.1212/01.wnl.0000194266.55694.1e · Cited by 373
Recommendations for the management of patients after heart valve surgery
Butchart, E. G., Gohlke-Bärwolf, C., Antunes, M. J., Tornos, P., De Caterina, R., Cormier, B., Prendergast, B., Iung, B., Bjornstad, H., Leport, C., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi426 · Cited by 358
Broderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., Mayberg, M., Morgenstern, L., Ogilvy, C. S., Vespa, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.183689 · Cited by 357
Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas
Hart, R. G., Tonarelli, S. B., & Pearce, L. A. (2005) · Stroke · doi:10.1161/01.str.0000170642.39876.f2 · Cited by 355
Self-citationMagnetic Resonance Imaging Detection of Microbleeds Before Thrombolysis: An Emerging Application
Kidwell, C. S., Saver, J. L., Villablanca, J. P., Duckwiler, G., Fredieu, A., Gough, K., Leary, M. C., Starkman, S., Gobin, Y. P., Jahan, R., et al. (2002) · Stroke · doi:10.1161/hs0102.101792 · Cited by 346
SMASH-U: A Proposal for Etiologic Classification of Intracerebral Hemorrhage
Meretoja, A., Strbian, D., Putaala, J., Curtze, S., Haapaniemi, E., Mustanoja, S., Sairanen, T., Satopää, J., Silvennoinen, H., Niemelä, M., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.661603 · Cited by 342
Huttner, H. B., Schellinger, P. D., Hartmann, M., Köhrmann, M., Juettler, E., Wikner, J., Mueller, S., Meyding-Lamade, U., Strobl, R., Mansmann, U., et al. (2006) · Stroke · doi:10.1161/01.str.0000221786.81354.d6 · Cited by 335
Major bleeding during anticoagulation after cerebral ischemia: Patterns and risk factors
Gorter, J. W., (SPIRIT), F. T. S. P. I. R. I. T., & Groups, E. A. F. T. (. S. (1999) · Neurology · doi:10.1212/wnl.53.6.1319 · Cited by 311
Treatment of intracerebral haemorrhage
Mayer, S. A., & Rincon, F. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70195-2 · Cited by 306
Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
Aguilar, M. I., Hart, R. G., Kase, C. S., Freeman, W. D., Hoeben, B. J., García, R. C., Ansell, J. E., Mayer, S. A., Norrving, B., Rosand, J., et al. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60970-1 · Cited by 306
Self-citationWarfarin-associated hemorrhage and cerebral amyloid angiopathy: A genetic and pathologic study
Rosand, J., Hylek, E. M., O’Donnell, H. C., & Greenberg, S. M. (2000) · Neurology · doi:10.1212/wnl.55.7.947 · Cited by 305
Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis
Eckman, M. H., Rosand, J., Knudsen, K. A., Singer, D. E., & Greenberg, S. M. (2003) · Stroke · doi:10.1161/01.str.0000078311.18928.16 · Cited by 304
Steiner, T., Rosand, J., & Diringer, M. (2006) · Stroke · doi:10.1161/01.str.0000196989.09900.f8 · Cited by 298
Eckman, M. H., Rosand, J., Greenberg, S. M., & Gage, B. F. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-00005 · Cited by 283
Moving the Tipping Point: The Decision to Anticoagulate Patients With Atrial Fibrillation
Eckman, M. H., Singer, D. E., Rosand, J., & Greenberg, S. M. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.958108 · Cited by 275
Risk of Bleeding With Dabigatran in Atrial Fibrillation
Hernandez, I., Baik, S. H., Piñera, A., & Zhang, Y. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5398 · Cited by 264
Retinal arterial changes correlate with cerebral small-vessel disease
Kwa, V. I. H., van der Sande, J. J., Stam, J., Tijmes, N., & Vrooland, J. L. (2002) · Neurology · doi:10.1212/01.wnl.0000033093.16450.5c · Cited by 211
Hanley, J. P. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.008904 · Cited by 215
Molinski, S. V., Shahani, V. M., MacKinnon, S. S., Morayniss, L. D., Laforet, M., Woollard, G., Kurji, N., Sanchez, C. G., Wodak, S. J., & Windemuth, A. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.115 · Cited by 17
Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhage
Diener, H.-C., Stanford, S., Abdul-Rahim, A., Christensen, L., Hougaard, K. D., Bakhai, A., Veltkamp, R., & Worthmann, H. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.945435 · Cited by 12
Metadata
- Authors
- Hart, R. G., Boop, B. S., & Anderson, D. C.
- Venue
- Stroke
- Published
- 1995-08
- Volume
- 26
- Issue
- 8
- Pages
- 1471-1477
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2031990245
- Cited by
- 541
- References
- 40
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.